Legal Opinion
In re Zoloft (Sertralinehydrochloride) Products Liability Litigation
District Court, E.D. Pennsylvania
Decided April 5, 2016No. MDL NO. 2342; 12-MD-2342PublishedCited by 16 opinions
1Opinion of the Court
Rufe, Judge.
OPINION
By Order filed April 17, 2012, the United States Judicial Panel on MultiDistrict Litigation transferred to this Court, for coordinated or consolidated pretrial proceedings, cases alleging that Zoloft (sertraline hydrochloride), “a prescription medication approved for the treatment of depression and other ailments, causes birth 'defects in children when their mothers ingest the drug while pregnant.”1 In rejecting arguments opposing centralization of the cases, the Panel determined that “while the specific birth defects alleged vary somewhat among the plaintiffs, all actions…
2Cases cited30 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- In Re Paoli Railroad Yard PCB LitigationCourt of Appeals for the Third Circuit · 1994
25 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Rudolph Karlo v. Pittsburgh Glass Works LLCCourt of Appeals for the Third Circuit · 2017
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- In re Mirena IUD Products Liability LitigationDistrict Court, S.D. New York · 2016
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
11 more not listed; retrieve them via the Exa API.